Related Experiment Video

Updated: Aug 11, 2026

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

[Antisense therapy in oncology: present situation]

D Morán González1, A Domínguez-Gil Hurlé

  • 1Servicio de Farmacia, Hospital Universitario de Salamanca. dmorang@usal.es

Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|November 5, 2005
PubMed

Insights

Antisense therapy offers a novel cancer treatment by blocking cancer-promoting genes. While showing short-term efficacy and safety in trials, long-term studies are needed to confirm its effectiveness and toxicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Context:

  • Antisense therapy presents a targeted approach to cancer treatment, distinct from traditional chemotherapy.
  • Gene regulation plays a critical role in cancer progression, making it a key target for novel therapies.

Purpose:

  • To review the significant aspects of antisense therapy as a novel therapeutic alternative in oncology.
  • To discuss the mechanism of action of antisense oligonucleotides in controlling cancer cell proliferation.

Summary:

  • Antisense therapy utilizes antisense oligonucleotides to specifically block the expression of genes driving cancer progression.
  • Clinical trials indicate promising short- to mid-term efficacy and safety profiles for this innovative treatment modality.
  • This approach aims to control cancer growth while minimizing harm to normal cells, potentially reducing side effects.

Impact:

  • Antisense therapy represents a promising molecular drug development for cancer treatment.
  • Further long-term studies are essential to fully establish the clinical effectiveness and comprehensive toxicological profile of antisense therapies.
  • This therapeutic strategy holds potential for a more targeted and less toxic cancer treatment paradigm.

More Related Videos

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...